[1. Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behcet’s disease: from Hippocrates to the third millennium. Brit J Ophthalmol. 2003; 87:1175-83.10.1136/bjo.87.9.1175]Open DOISearch in Google Scholar
[2. Onder M, Gurer MA. Behcet’s disease: an enigmatic vasculitis. Clin Dermatol. 1999; 17:571-6.10.1016/S0738-081X(99)00063-2]Open DOISearch in Google Scholar
[3. Evereklioglu C. Current concepts in the etiology and treatment of Behcet disease. Surv Ophthalmol. 2005; 50:297-350.10.1016/j.survophthal.2005.04.00915967189]Open DOISearch in Google Scholar
[4. Direskeneli H. Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis. 2001; 60:996-1002.10.1136/ard.60.11.996175340511602462]Open DOISearch in Google Scholar
[5. Mumcu G, Inanc N, Yavuz S, Direskeneli H. The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behcet’s disease. Clin Exp Rheumatol. 2007; 25:S27-33.]Search in Google Scholar
[6. Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet’s disease. Clin Exp Immunol. 2005; 139:371-8.10.1111/j.1365-2249.2005.02695.x180927715654837]Open DOISearch in Google Scholar
[7. Amoura Z, Guillaume M, Caillat-Zucman S, Wechsler B, Piette JC. Pathophysiology of Behcet’s disease (Physiopathologie de la maladie de Behcet). Rev Med Interne. 2006; 27:843-53.10.1016/j.revmed.2006.02.01416828934]Open DOISearch in Google Scholar
[8. Borhani Haghighi A, Pourmand R, Nikseresht AR. Neuro-Behcet Disease. Neurologist. 2005; 11:80-9.10.1097/01.nrl.0000156343.16797.c415733330]Open DOISearch in Google Scholar
[9. Zouboulis CC. HLA-independent antibacterial host response toward Th1 immunity mediated by IL-12: a new concept for the pathogenesis of Adamantiades- Behcet’s disease. J Invest Dermatol. 2006; 126:1444-7.10.1038/sj.jid.570028116778812]Open DOISearch in Google Scholar
[10. Yabuki K, Mizuki N, Ota M, Katsuyama Y, Palimeris G, Stavropoulos C, et al. Association of MICA gene and HLA-B*5101 with Behcet’s disease in Greece. Invest Ophthalmol Vis Sci. 1999; 40:1921-6.]Search in Google Scholar
[11. Zierhut M, Mizuki N, Ohno S, Inoko H, Gul A, Onoe K, et al. Human genome and diseases: review- immunology and functional genomics of Behcet’s disease. Cell Mol Life Sci. 2003; 60:1903-22.10.1007/s00018-003-2333-314523551]Open DOISearch in Google Scholar
[12. Kalayciyan A, Zouboulis CC. An update on Behcet’s disease. J Eur Acad Dermatol Venereol. 2006; 21:1-10.10.1111/j.1468-3083.2006.01863.x17207160]Search in Google Scholar
[13. Gul A. Standard and novel therapeutic approaches to Behcet’s disease. Drugs. 2007; 67:2013-22.10.2165/00003495-200767140-0000417883285]Open DOISearch in Google Scholar
[14. Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC. Epidemiology and clinical manifestations of Adamantiades-Behcet disease in Germany - Current pathogenetic concepts and therapeutic possibilities. J German Soc Dermatol. 2006; 4:49-66.10.1111/j.1610-0387.2006.05841.x16503932]Search in Google Scholar
[15. Zouboulis CC, May T. Pathogenesis of Adamantiades- Behcet’s disease. Med Microbiol Immunol. 2003; 192: 149-55.10.1007/s00430-002-0167-512684757]Open DOISearch in Google Scholar
[16. Zouboulis CC, Turnbull JR, Muhlradt PF. High seroprevalence of anti-Mycoplasma fermentans antibodies in patients with malignant aphthosis. J Invest Dermatol. 2003; 121:211-2.10.1046/j.1523-1747.2003.12303.x12839585]Search in Google Scholar
[17. Belizna CC, Hamidou MA, Levesque H, Guillevin L, Shoenfeld Y. Infection and vasculitis. Rheumatology. 2009; 48:475-82.10.1093/rheumatology/kep026710723719258377]Search in Google Scholar
[18. Kaneko F, Oyama N, Yanagihori H, Isogai E, Yokota K, Oguma K. The role of streptococcal hypersensitivity in the pathogenesis of Behcet’s disease. Eur J Dermatol. 2008; 18:489-98.]Search in Google Scholar
[19. Emmi L, Brugnolo F, Salvati G, Marchione T. Immunopathological aspects of Behcet’s disease (editorial). Clin Exp Rheumatol. 1995; 13:687-91.]Search in Google Scholar
[20. Deutera CME, Kotter I, Wallace GR, Murray PI, Stubiger N, Zierhut M. Behcet’s disease: ocular effects and treatment. Prog Retin Eye Res. 2008; 27: 111-36.10.1016/j.preteyeres.2007.09.00218035584]Open DOISearch in Google Scholar
[21. Onder M, Gurer MA. The multiple faces of Behcet’s disease and its aetiological factors. J Eur Acad Dermatol Venerol. 2001; 15:126-36.10.1046/j.1468-3083.2001.00251.x11495519]Open DOISearch in Google Scholar
[22. Mizuki N, Ohno SH. Immunogenetic studies of Behcet’s disease. Revue du rhumatisme. 1996; 63: 520-7.]Search in Google Scholar
[23. Barnes CG. Behcet’s syndrome. Top Rev. 1991; 18.]Search in Google Scholar
[24. Mumcu G, Ergun T, Inanc N, Fresko I, Atalay T, Hayran O, et al. Oral health is impaired in Behcet’s disease and is associated with disease severity. Rheumatology. 2004; 43:1028-33.10.1093/rheumatology/keh23615161982]Open DOISearch in Google Scholar
[25. Akman A, Sallakci N, Kacaroglu H, Tosun O, Yavuzer U, Alpsoy E, et al. Relationship between periodontal findings and the TNF-á Gene 1031T/C polymorphism in Turkish patients with Behcet’s disease. J Eur Acad Dermatol Venereol. 2008; 22:950-7.10.1111/j.1468-3083.2008.02678.x18355201]Open DOISearch in Google Scholar
[26. Arabaci T, Kara C, Cicek Y. Relationship between periodontal parameters and Behcet’s disease and evaluation of different treatments for oral recurrent aphthous stomatitis. J Periodont Res. 2009; 44:718-25.10.1111/j.1600-0765.2008.01183.x19076988]Open DOISearch in Google Scholar
[27. Mizushima Y, Hoshi K, Matsuda T, Takahashi M, Takada H, Kuribayashi S, et al. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet’s disease-a multicenter study. The Behcet’s Disease Research Committee of Japan. J Rheumatol. 1989; 16: 506-11.]Search in Google Scholar
[28. Tsuchida M, Mineshita S, Okonogi H, Sugimor K, Hoshi K, Horiuchi T, et al. The role of an uncommon type of oral Streptococcus Sanguis in the etiology of Behcet’s disease. Environ Health Prev Med. 1997; 2:59-63.10.1007/BF02931965]Open DOISearch in Google Scholar
[29. Mizushima Y, Matsuda T, Hoshi K, Ohno S. Induction of Behcet’s disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol. 1988; 15:1029-30.]Search in Google Scholar
[30. Choi SM, Choi YJ, Kim JT, Lee SH, Park MS, Kim BC, et al. A case of recurrent neuro-Behcet’s disease after tooth extraction. J Korean Med Sci. 2010; 25:185-7.10.3346/jkms.2010.25.1.185]Open DOISearch in Google Scholar
[31. Karacayli U, Mumcu G, Simsek I, Pay S, Kose O, Erdem H, et al. The close association between dental and periodontal treatments and oral ulcer course in Behcet’s disease: a prospective clinical study. J Oral Pathol Med. 2009; 38:410-5.10.1111/j.1600-0714.2009.00765.x]Open DOISearch in Google Scholar
[32. Baharav E, Weinberger A, Mor F. Experimental models of Behcet’s disease. Drug Discov Today: Disease Model. 2006; 3:11-4.10.1016/j.ddmod.2006.03.008]Search in Google Scholar
[33. Narikawa S, Suzuki Y, Takahashi M, Furukawa A, Sakane T, Mizushima Y. Streptococcus oralis previously identified as uncommon ‘Streptococcus sanguis’ in Behcet’s disease. Arch Oral Biol. 1995; 40: 685-90.10.1016/0003-9969(95)00042-N]Open DOISearch in Google Scholar
[34. Yoshikawa K, Kotake S, Kubota T, Kimura K, Isogai E, Fujii N. Cloning and sequencing of BES-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behcet’s disease. Zentralblatt fur Bakteriologie. 1998; 287: 449-60.10.1016/S0934-8840(98)80184-9]Search in Google Scholar
[35. Tojo M, Yanagihori H, Zheng X, Oyama N, Isogai E, Kimura K, et al. Bes-1 DNA fragment encoding streptococcal antigen in skin lesions from patients with Behcet’s disease. J Appl Res Clin Exp Ther. 2003; 3:232-8.]Search in Google Scholar
[36. Kurauchi T, Yokota K, Matsuo T, Fujinami Y, Isogai E, Isogai H, et al. Neutrophil and lymphocyte responses to oral Streptococcus in Adamantiades-Behcet’s disease. FEMS Immunol Med Microbiol. 2005; 43: 125-31.10.1016/j.femsim.2004.07.00715681141]Open DOISearch in Google Scholar
[37. Yanagihori H, Oyama N, Nakamura K, Mizuki N, Oguma K, Kaneko F. Role of IL-12B promoter polymorphism in Adamantiades-Behcet’s disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen. J Invest Dermatol. 2006; 126:1534-40.10.1038/sj.jid.570020316514412]Open DOISearch in Google Scholar
[38. Oh SH, Lee KY, Lee JH, Bang D. Clinical manifestations associated with high titer of anti-streptolysin O in Behcet’s disease. Clin Rheumatol. 2008; 27:999-1003.10.1007/s10067-008-0844-x18246379]Open DOISearch in Google Scholar
[39. Yokota K, Hayashi S, Fuji N, Yoshikawa K, Kotake S, Isogai E, et al. Antibody response to oral Streptococci in Behcet’s disease. Microbiol Immunol. 1992; 36: 815-22.10.1111/j.1348-0421.1992.tb02083.x1474932]Open DOISearch in Google Scholar
[40. Namba K, Ueno T, Okita M. Behcet’s disease and streptococcal infection. Jpn J Ophthalmol. 1986; 30: 385-401.]Search in Google Scholar
[41. Hirohata S, Oka H, Mizushima Y. Streptococcal-related antigens stimulate production of IL6 and interferon-ã by T cells from patients with Behcet’s disease. Cell Immunol. 1992; 140:410-9.10.1016/0008-8749(92)90207-6]Open DOISearch in Google Scholar
[42. Isogai E, Isogai H, Kotake S, Ohno S, Kimura K, Oguma K. Role of Streptococcus sanguis and traumatic factors in Behcet’s disease. J Appl Res Clin Exp Ther. 2003; 3:64-75.]Search in Google Scholar
[43. Hatemi G, Bahar H, Uysal S, Mat C, Gogus F, Masatlioglu S, et al. The pustular skin lesions in Behcet’s syndrome are not sterile. Ann Rheum Dis. 2004; 63:1450-2.10.1136/ard.2003.017467]Open DOISearch in Google Scholar
[44. Suga Y, Tsuboi R, Kobayashi S, Ogawa H. A case of Behcet’s disease aggravated by gingival infection with methicillin-resistant Staphylococcus aureus. Brit J Dermatol. 1995; 133:319-21.10.1111/j.1365-2133.1995.tb02640.x]Open DOISearch in Google Scholar
[45. Keser G, Erdogan M, Aydemir S, Karatas T, Aksu K, Tunger A, et al. Nasal Staphylococcus aureus carriage is not increased in Behcet’s disease. Rheumatol Int. 2005; 25:567-8.10.1007/s00296-005-0593-y]Open DOISearch in Google Scholar
[46. Onen F, Tuncer D, Akar S, Birlik M, Akkoc N. Seroprevalence of Borrelia burgdorferi in patients with Behcet’s disease. Rheumatol Int. 2003; 23:289-93.10.1007/s00296-003-0313-4]Open DOISearch in Google Scholar
[47. Isogai E, Isogai H, Kotake S, Yoshikawa K, Ichiishi A, Kosaka S, et al. Detection of antibodies against Borrelia burgdorferi in patients with uveitis. Am J Ophthalmol. 1991; 112:23-30.10.1016/S0002-9394(14)76207-5]Open DOISearch in Google Scholar
[48. Ayaslioglu E, Erkek E, Kaygusuz S, Kilic D, Inal A, Keskun G. Analysis of Borrelia Burgdorferi antibody seroprevalence in patients with Behcet’s disease using 3 different serological assays. Turk J Med Sci. 2004; 34:375-8.]Search in Google Scholar
[49. di Meo N, Quaranta L, Crisman G, Trevisan G. Adamantiades Behcet disease triggered by a tick bite and or borrelia infection. J Eur Acad Dermatol Venereol. 2009; 23:1198-9.10.1111/j.1468-3083.2009.03105.x19573027]Search in Google Scholar
[50. Iliopoulos A, Kedikoglou S, Laxanis S, Kourouklis S, Katsaros E. A case of tuberculous meningoencephalitis in a patient with Behcet’s disease. Clin Rheumatol. 2005; 25:121-2.10.1007/s10067-005-1135-415902513]Search in Google Scholar
[51. Apan TZ, Gursel R, Dolgun A. Increased seropositivity of Helicobacter pylori cytotoxin-associated gene-A in Behcet’s disease. Clin Rheumatol. 2007; 26:885-9.10.1007/s10067-006-0416-x17021670]Open DOISearch in Google Scholar
[52. Yildirim B, Ozturk MA, Unal S. The anti-Helicobacter pylori antibiotherapy for the treatment of recurrent oral aphthous ulcers in a patient with Behcet’s syndrome. Rheumatol Int. 2009; 29:477-8.10.1007/s00296-008-0709-218802701]Open DOISearch in Google Scholar
[53. Avc O, Ellidokuz E, Imek I, Buyukgebiz B, Gune AT. Helicobacter pylori and Behcet’s disease. Dermatology. 1999; 199:140-3.10.1159/000018221]Open DOISearch in Google Scholar
[54. Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S. H. pylori infection in patients with Behcet’s disease. World J Gastroenterol. 2007; 13:2983-5.10.3748/wjg.v13.i21.2983]Open DOISearch in Google Scholar
[55. Cakmak SK, Cakmak A, Gul U, Sulaimanov M, Bingol P, Hazinedarolu MS. Upper gastrointestinal abnormalities and Helicobacter pylori in Behcet’s disease. Int J Dermatol. 2009; 48:1174-6.10.1111/j.1365-4632.2009.04145.x]Open DOISearch in Google Scholar
[56. Gunduz A, Gunduz A, Cumurcu T, Seyrek A. Conjunctival flora in Behcet patients. Can J Ophthalmol. 2008; 43: 476-9.10.3129/i08-089]Open DOISearch in Google Scholar
[57. Ayaslioglu E, Duzgun N, Erkek E, Inal A. Evidence of chronic Chlamydia pneumoniae infection in patients with Behcet’s disease. Scand J Infect Dis. 2004; 36: 428-30.10.1080/00365540410020730]Open DOISearch in Google Scholar
[58. Mandal K, Jahangiri M, Xu Q. Autoimmunity to heat shock proteins in atherosclerosis. Autoimmun Rev. 2004; 3:31-7.10.1016/S1568-9972(03)00088-0]Open DOISearch in Google Scholar
[59. Hauet-Broere F, Wieten L, Guichelaar T, Berlo S, van der Zee R, Van Eden W. Heat shock proteins induce T cell regulation of chronic inflammation. Ann Rheum Dis. 2006; 65 (Suppl III):iii65-8.10.1136/ard.2006.058495]Search in Google Scholar
[60. Direskeneli H, Saruhan-Direskeneli G. The role of heat shock proteins in Behcet’s disease. Clin Exp Rheumatol. 2003; 4 (Suppl):S44-8.]Search in Google Scholar
[61. Zierhut M, Mizuki N, Ohno S, Inoko H, Gul A, Onoe K, et al. Immunology and functional genomics of Behcet’s disease. Cell Mol Life Sci. 2003; 60:1903-22.10.1007/s00018-003-2333-3]Open DOISearch in Google Scholar
[62. Saruhan-Direskeneli G, Celet B, Eksioglu-Demiralp E, Direskeneli H. Human HSP 60 peptide responsive T cell lines are similarly present in both Behcet’s disease patients and healthy controls. Immunol Lett. 2001; 79:203-8.10.1016/S0165-2478(01)00280-2]Search in Google Scholar
[63. Shaker O, Ay El-Deen MA, El Hadidi H, Grace BD, El Sherif H, Abdel Halim A. The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behcet’s disease. Brit J Dermatol. 2007; 156:32-7.10.1111/j.1365-2133.2006.07536.x17199563]Search in Google Scholar
[64. Lund PA, Large AT, Kapatai G. The chaperonins: perspectives from the Archaea. Biochem Soc Trans. 2003; 31:681-85.10.1042/bst031068112773182]Open DOISearch in Google Scholar
[65. Deniz E, Guc U, Buyukbabani N, Gul A. HSP 60 expression in recurrent oral ulcerations of Behcet’s disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 110:196-200.10.1016/j.tripleo.2010.03.02020580281]Search in Google Scholar
[66. Pay S, Simsek I, Erdem H, Dinc A. Immunopathogenesis of Behcet’s disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int. 2007; 27:417-24.10.1007/s00296-006-0281-617171346]Open DOISearch in Google Scholar
[67. Celet B, Akman-Demir G, Serdaroglu P, Yentur SP, Tas’ci B, Van Noort JM, et al. Anti-áB-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol. 2000; 247:935-9.10.1007/s00415007004911200685]Search in Google Scholar
[68. Ergun T, Ince U, Eksioglu-Demiralp E, Direskeneli H, Gurbuz O, Gurses L, et al. HSP 60 expression in mucocutaneous lesions of Behcet’s disease. J Am Acad Dermatol. 2001; 45:904-9.10.1067/mjd.2001.11772811712037]Search in Google Scholar
[69. Kurokawa MS, Suzuki N. Behcet’s disease. Clin Exp Med. 2004; 3:10-20.10.1007/s10238-004-0033-415598081]Open DOISearch in Google Scholar
[70. Birtas-Atesoglu E, Inanc N, Yavuz S, Ergun T, Direskeneli H. Serum levels of free heat shock protein 70 and anti-HSP70 are elevated in Behcet’s disease. Clin Exp Rheumatol. 2008; 26:S96-8.]Search in Google Scholar
[71. Karadag R, Koca C, Totan Y, Yagci R, Aydin M, Karadag AS, et al. Comparison of serum levels of IL-6, IL-8, TNF-á, C reactive protein and heat shock protein 70 in patients with active or inactive Behcet’s disease. Turk J Med Sci. 2010; 40:57-62.10.3906/sag-0906-3]Search in Google Scholar
[72. Yavuz S, Elbir Y, Tulunay A, Eksioglu-Demiralp E, Direskeneli H. Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet disease etiopathogenesis. Rheumatol Int. 2008; 28:401-6.10.1007/s00296-007-0470-y17934735]Open DOISearch in Google Scholar
[73. Kirino Y, Takeno M, Watanabe R, Murakami S, Kobayashi M, Ideguchi H, et al. Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behcet’s disease. Arthritis Res Ther. 2008; 10: R16.10.1186/ar2367237447218234118]Search in Google Scholar
[74. Lancaster GI, Febbraio MA. Mechanisms of stressinduced cellular HSP72 release. In: Asea AAA, De Maio A, editors. Heat shock proteins: potent mediators of inflammation and immunity. The Netherlands, Dordrecht: Springer; 2007, p. 31-7.10.1007/978-1-4020-5585-0_3]Search in Google Scholar
[75. Meguro A, Ota M, Katsuyama Y, Oka A, Ohno S, Inoko H, et al. Association of the toll-like receptor 4 gene polymorphisms with Behcet’s disease. Ann Rheum Dis. 2008; 67:725-7.10.1136/ard.2007.07987118408113]Search in Google Scholar
[76. Miura T, Ishihara K, Kato T, Kimizuka R, Miyabe H, Ando T, et al. Detection of heat shock proteins but not superantigen by isolated oral bacteria from patients with Behcet’s disease. Oral Microbiol Immunol. 2005; 20:167-71.10.1111/j.1399-302X.2005.00207.x]Open DOISearch in Google Scholar
[77. Van Eden W. Heat shock proteins are targets for T cell regulation: how microbial HSP induce IL10 producing anti-inflammatory T cells. In: Asea AAA, De Maio A, editors. Heat shock proteins: potent mediators of inflammation and immunity. The Netherlands, Dordrecht: Springer; 2007, p. 289-308.10.1007/978-1-4020-5585-0_18]Search in Google Scholar
[78. Fortune F, Walker J, Lefrancois M, Lehner T. The expression of carbohydrate antigens in activated T cells and in autoimmune diseases. Scand J Immunol. 1994, 40:636-42.10.1111/j.1365-3083.1994.tb03516.x]Open DOISearch in Google Scholar
[79. Sakane T, Suzuki N, Nagafuchi H. Etiopathology of Behcet’s disease: immunological aspects. Yonsei Med J. 1997, 38:350-8.10.3349/ymj.1997.38.6.350]Open DOISearch in Google Scholar
[80. Escudier M, Bagan J, Scully C. Mucosal diseases series: number VII Behcet’s disease (Adamantiades syndrome). Oral Dis. 2006, 12:78-84.10.1111/j.1601-0825.2005.01144.x]Open DOISearch in Google Scholar
[81. Direskeneli H. Autoimmunity vs autoinflammation in Behcet’s disease: do we oversimplify a complex disorder? Rheumatology. 2006; 45:1461-5.10.1093/rheumatology/kel329]Open DOISearch in Google Scholar
[82. Kaneko S, Suzuki N, Yamashita N, Nagafuchi H, Nakajima T, Wakisaka S, et al. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet’s disease (BD) in Japan. Clin Exp Immunol. 1997; 108:204-12.10.1046/j.1365-2249.1997.3611265.x]Search in Google Scholar
[83. Pervin K, Childerstone A, Shinnick T, Mizushima Y, Van der Zee R, Hasan A, et al. T cell epitope expression of mycobacterial and homologous human 65- kilodalton heat shock protein peptides in short term cell lines from patients with Behcet’s disease. J Immunol. 1993; 151:2273-82.]Search in Google Scholar
[84. Direskeneli H, Eksioglu-Demiralp E, Yavuz S, Ergun T, Shinnick T, Lehner T, et al. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behcet’s disease. J Rheumatol. 2000; 27: 708-13.]Search in Google Scholar
[85. Lehner T, Lavery E, Smith R, Van Der Zee R, Mizushima Y, Shinnick T. Association between the 65-kilodalton heat shock protein, Streptococcus sanguinis, and the corresponding antibodies in Behcet’s syndrome. Infect Immun. 1991; 59:1434-41.10.1128/iai.59.4.1434-1441.1991]Search in Google Scholar
[86. Gaston JSH, Hasan A, Fortune F, Wilson A, Lehner T. Role of ãäT cells in Behcet’s disease. Lancet. 1996; 347:1631-2.10.1016/S0140-6736(96)91121-6]Open DOISearch in Google Scholar
[87. Uchio E, Stanford M, Hasan A, Satoh S, Ohno S, Shinnick T, et al. HSP-derived peptides inducing uveitis and IgG and IgA antibodies. Exp Eye Res. 1998; 67:719-27.10.1006/exer.1998.05749990336]Open DOISearch in Google Scholar
[88. Hu W, Hasan A, Wilson A, Stanford MR, Li-Yang Y, Todryk S, et al. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol. 1998; 28:2444-55.10.1002/(SICI)1521-4141(199808)28:08<2444::AID-IMMU2444>3.0.CO;2-N]Search in Google Scholar
[89. Stanford M, Whittall T, Bergmeier LA, Lindblad M, Lundin S, Shinnick T, et al. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet’s disease. Clin Exp Immunol. 2004; 137:201-8.10.1111/j.1365-2249.2004.02520.x]Search in Google Scholar
[90. Nagafuchi H, Takeno M, Yoshikawa H, Kurokawa MS, Nara K, Takada E, et al. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet’s disease. Clin Exp Immunol. 2005; 139:363-70.10.1111/j.1365-2249.2004.02688.x]Open DOISearch in Google Scholar
[91. G⃞l A. Behcet’s disease: An update on the pathogenesis. Clin Exp Rheumatol. 2001; 19:S6-12.]Search in Google Scholar
[92. Tanaka T, Yamakawa N, Koike N, Suzuki J, Mizuno F, Usui M. Behcet’s disease and antibody titers to various heat-shock protein 60s. Ocul Immunol Inflamm. 1999; 7:69-74.10.1076/ocii.7.2.69.4018]Search in Google Scholar
[93. Kim H. Diagnostic significance of antibodies to heat shock proteins. Clin Chim Acta. 2003; 337:1-10.10.1016/S0009-8981(03)00340-1]Open DOISearch in Google Scholar
[94. Isogai E, Isogai H, Kotake S, Ohno S, Ishihara M, Aoki K, et al. Antibody cross reactivity from sera of patients with Behcet’s disease with synthetic peptides that have homologies with proteins from Streptococcus sanguinis. J Appl Res. 2002; 2.]Search in Google Scholar
[95. Tasci B, Direskeneli H, Serdaroglu P, Akman-Demir G, Eraksoy M, Saruhan-Direskeneli G. Humoral immune response to mycobacterial heat shock proteins (hsp) 65 in the cerebrospinal fluid of neuro-Behcet’s patients. Clin Exp Immunol. 1998; 113:100-4.10.1046/j.1365-2249.1998.00620.x]Open DOISearch in Google Scholar
[96. Ramadan A, Nussenblatt RB, de Smet MD. Elevation of anti-heat shock protein 70 antibodies in patients with uveitis. Invest Ophthalmol Vis Sci. 1996; 37: S458.]Search in Google Scholar
[97. Yurdakul S, Yazici H. Behcet’s syndrome. Best Pract Res Clin Rheumatol. 2008; 22:793-809.10.1016/j.berh.2008.08.005]Open DOISearch in Google Scholar
[98. Calguneri M, Kiraz S, Ertenli I, Benekli M, Karaarslan Y, Celik I. The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet’s disease. Arthritis Rheum. 1996; 39: 2062-5.10.1002/art.1780391216]Open DOISearch in Google Scholar
[99. Calguneri M, Ertenli I, Kiraz S, Erman M, Celik I. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet’s disease. Dermatology. 1996; 192:125-8.10.1159/000246336]Open DOISearch in Google Scholar
[100. Mumcu G, Ergun T, Elbir Y, Eksioglu-Demiralp E, Yavuz S, Atalay T, et al. Clinical and immunological effects of azithromycin in Behcet’s disease. J Oral Pathol Med. 2005; 34:13-6.10.1111/j.1600-0714.2004.00265.x]Open DOISearch in Google Scholar
[101. Kaneko F, Oyama N, Nishibu A. Streptococcal infection in the pathogenesis of Behcet’s disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J. 1997; 38:444-54.10.3349/ymj.1997.38.6.444]Open DOISearch in Google Scholar
[102. Rozin AP, Hatemi G, Yazici H. Is Behcet’s syndrome associated with infection? (multiple letters). Ann Rheum Dis. 2005; 64:513-5.]Search in Google Scholar
[103. Lee S, Bang D, Cho YH, Lee ES, Sohn S. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet’s disease. Arch Dermatol Res. 1996; 288:179-83.10.1007/BF02505221]Open DOISearch in Google Scholar
[104. Tojo M, Zheng X, Yanagihori H, Oyama N, Takahashi K, Nakamura K, et al. Detection of herpes virus genomes in skin lesions from patients with Behcet’s disease and other related inflammatory diseases. Acta Derm Venereol. 2003; 83:124-7.10.1080/00015550310007472]Open DOISearch in Google Scholar
[105. Lee ES, Lee S, Bang D, Sohn S. Herpes simplex virus detection by polymerase chain reaction in intestinal ulcer of patients with Behcet’s disease. Revue du Rhumatisme. 1996; 63:531.]Search in Google Scholar
[106. Bang D, Cho YH, Choi HJ, Lee S, Sohn S. Detection of herpes simplex virus DNA by polymerase chain reaction in genital ulcer of patients with Behcet’s disease. Revue du Rhumatisme. 1996; 63:532.]Search in Google Scholar
[107. Studd M, McCance DJ, Lehner T. Detection of HSV-1 DNA in patients with Behcet’s syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol. 1991; 34:39-43.10.1099/00222615-34-1-39]Open DOISearch in Google Scholar
[108. Nomura Y, Kitteringham N, Shiba K, Goseki M, Kimura A, Mineshita S. Use of the highly sensitive PCR method to detect the Herpes simplex virus type 1 genome and its expression in samples from Behcet disease patients. J Med Dent Sci. 1998; 45:51-8.]Search in Google Scholar
[109. Sohn S, Lee ES, Bang D, Lee S. Behcet’s disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol. 1998; 8:21-3.]Search in Google Scholar
[110. Sohn S, Lee ES, Kwon HJ, Lee SI, Bang D, Lee S. Expression of Th2 cytokines decreases the development of and improves Behcet’s disease-like symptoms induced by herpes simplex virus in mice. J Infect Dis. 2001; 183:1180-6.10.1086/319681]Open DOISearch in Google Scholar
[111. Lee SI, Kwon HJ, Lee ES, Yang BC, Bang D, Lee S, et al. Using pCIN-mIL-4 DNA vector to express mRNA and protein and to improve herpes simplex virusinduced Behcet’s disease symptoms in mice. Vaccine. 2007; 25:7047-55.10.1016/j.vaccine.2007.07.062]Open DOISearch in Google Scholar
[112. Sohn S, Lee ES., Lee S. The correlation of MHC haplotype and development of Behcet’s disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci. 2001; 26:173-81.10.1016/S0923-1811(01)00086-X]Open DOISearch in Google Scholar
[113. Lee ES, Kim YA, Kwon HJ, Bang D, Lee S, Sohn S. Thalidomide upregulates macrophage inflammatory protein-1a in a herpes simplex virus-induced Behcet’s disease-like animal model. Arch Dermatol Res. 2004; 296:175-81.]Search in Google Scholar
[114. Bang D, Choi B, Kwon HJ, Lee ES, Lee S, Sohn S. Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behcet’s disease mouse model. Eur J Pharmacol. 2008; 598:112-7.10.1016/j.ejphar.2008.09.00518823974]Open DOISearch in Google Scholar
[115. Shim J, Byun HO, Lee YD, Lee ES, Sohn S. Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet’s disease-like mouse model. Gene Ther. 2009; 16:415-25.10.1038/gt.2008.18019092856]Open DOISearch in Google Scholar
[116. Sohn S, Lutz M, Kwon HJ, Konwalinka G, Lee S, Schirmer M. Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades- Behcet’s disease-like mouse model. Exp Dermatol. 2004; 13:630-4.10.1111/j.0906-6705.2004.00210.x15447723]Open DOISearch in Google Scholar
[117. Choi B, Hwang Y, Kwon HJ, Lee ES, Park KS, Bang D, et al. Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model. J Dermatol Sci. 2008; 52:87-97.10.1016/j.jdermsci.2008.05.001]Open DOISearch in Google Scholar
[118. Sohn S, Bang D, Lee SI, Kim YA, Lee ES, Ha JY, et al. Combined treatment with colchicine and Herba Taraxaci (Tarazacum mongolicum Hand.-Mazz.) attenuates Behcet’s disease-like symptoms in mice and influences the expressions of cytokines. Int Immunopharmacol. 2003; 3:713-21.10.1016/S1567-5769(03)00071-7]Open DOISearch in Google Scholar
[119. Eglin RP, Lehner T, Subak-Sharpe JH. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet’s syndrome and recurrent oral ulcers. Lancet. 1982; 2: 1356-61.10.1016/S0140-6736(82)91268-5]Open DOISearch in Google Scholar
[120. Sugata K, Enomoto Y, Sugiyama H, Fujita A, Miyake F, Asano Y, et al. Single episode of Behcet’s diseaselike symptoms caused by herpes simplex virus reactivation. Pediatr Int. 2009; 51:577-8.10.1111/j.1442-200X.2009.02869.x19674368]Open DOISearch in Google Scholar
[121. Sanchez Roman J, Castillo Palma MJ, Torronteras Santiago R, Varela Aguilar JM, Lopez Checa F, Sanchez Garcia F. Type I herpes virus, HLA phenotype and Behcet disease [Virus herpes tipo I, fenotipo HLA y enfermedad de Behcet.] Medicina Clinica. 1992; 98:366-8.]Search in Google Scholar
[122. Sohn S, Bang D, Lee ES, Kwon HJ, Lee SI, Lee S. Experimental studies on the antiviral agent famciclovir in Behcet’s disease symptoms in ICR mice. Brit J Dermatol. 2001; 145:799-804.10.1046/j.1365-2133.2001.04498.x11736905]Open DOISearch in Google Scholar
[123. Sun A, Chang JG, Kao CL, Liu BY, Wang JT, Chu CT, et al. Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behcet’s disease. J Oral Pathol Med. 1996; 25:212-8.10.1111/j.1600-0714.1996.tb01374.x8835817]Open DOISearch in Google Scholar
[124. Lee EB, Kwon YJ, Shin KC, Song YW, Park CG, Hwang ES, et al. Decreased serum level of antibody against human cytomegalovirus in patients with Behcet’s disease. Rheumatol Int. 2005; 25:33-6.10.1007/s00296-003-0394-014600786]Open DOISearch in Google Scholar
[125. Akdeniz S, Harman M, Atmaca S, Akpolat N. The seroprevalence of varicella zoster antibodies in Behcet’s and other skin diseases. Eur J Epidemiol. 2003; 18:91-3.10.1023/A:1022537209948]Search in Google Scholar
[126. Aksu K, Kabasakal Y, Saymer A, Keser G, Oksel F, Bilgic A, et al. Prevalences of hepatitis A, B, C and E viruses in Behcet’s disease. Rheumatology. 1999; 38: 1279-81.10.1093/rheumatology/38.12.127910587560]Open DOISearch in Google Scholar
[127. Hadziyannis SJ. Skin diseases associated with hepatitis C virus infection. J Eur Acad Dermatol Venereol. 1998; 10:12-21.10.1111/j.1468-3083.1998.tb00922.x]Open DOISearch in Google Scholar
[128. Erkek E, Ayaslioglu E, Erkek AB, Kurtipek GS, Bagci Y. Response to vaccination against hepatitis B in patients with Behcet’s disease. J Gastroenterol Hepatol. 2005; 20:1508-11.10.1111/j.1440-1746.2005.03903.x16174066]Open DOISearch in Google Scholar
[129. Ozkan S, Toklu T, Ilknur T, Abacioglu H, Soyal MC, Gunes AT. Is there any association between hepatitis G virus (HGV), other hepatitis viruses (HBV, HCV) and Behcet’s disease? J Dermatol. 2005, 32:361-4.10.1111/j.1346-8138.2005.tb00907.x16043898]Open DOISearch in Google Scholar
[130. Farajzadeh S, Shakibi MR, Moghaddam SD, Rahnama Z. Behcet disease: clinical spectrum and association with hepatitis B and C viruses. East Mediterr Health J. 2005; 11:68-72.]Search in Google Scholar
[131. Kiraz S, Ertenli I, Benekli M, Calguneri M. Parvovirus B19 infection in Behcet’s disease. Clin Exp Rheumatol. 1996; 14:71-3.]Search in Google Scholar
[132. Baskan EB, Yilmaz E, Saricaoglu H, Alkan G, Ercan I, Mistik R, et al. Detection of parvovirus B19 DNA in the lesional skin of patients with Behcet’s disease. Clin Exp Dermatol. 2007; 32:186-90.10.1111/j.1365-2230.2006.02330.x17250756]Search in Google Scholar
[133. Touge C, Agawa H, Sairenji T, Inoue Y. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis. Arch Virol. 2006; 151: 895-903.10.1007/s00705-005-0686-716362642]Open DOISearch in Google Scholar
[134. Sun A, Chang JG, Chu CT, Liu BY, Yuan JH, Chiang CP. Preliminary evidence for an association of Epstein- Barr virus with pre-ulcerative oral lesions in patients with recurrent aphthous ulcers or Behcet’s disease. J Oral Pathol Med. 1998; 27:168-75.10.1111/j.1600-0714.1998.tb01935.x9563572]Search in Google Scholar
[135. Rezaieyazdi Z, Shoja-e-razavi G. Interferon alfa-2b therapy in mucocutaneous manifestations of Behcet’s disease. Iran J Med Sci. 2005; 30:105-9.]Search in Google Scholar
[136. Buskila D, Gladman DD, Gilmore J, Salit IE. Behcet’s disease in a patient with immunodeficiency virus infection. Ann Rheum Dis. 1991; 50:115-6.10.1136/ard.50.2.11510043501998386]Open DOISearch in Google Scholar
[137. Mahajan V, Sharma NL, Sharma VC, Sharma RC, Sarin S. Behcet’s disease with HIV infection: Response to antiretroviral therapy. Indian J Dermatol Venereol Leprol. 2005; 71:276-8.10.4103/0378-6323.1662316394440]Search in Google Scholar
[138. Hayasaka S, Noda S, Setogawa T. Increased Darabinitol/ creatinine ratio in sera of patients with Behcet’s disease during an active phase. Brit J Ophthalmol. 1993; 77:39-40.10.1136/bjo.77.1.395044218435398]Open DOISearch in Google Scholar
[139. Monselise A, Weinberger A, Monselise Y, Fraser A, Sulkes JF, Krause I. Anti-Saccharomyces cerevisiae antibodies in Behcet’s disease - a familial study. Clin Exp Rheumatol. 2006; 24:S87-90.]Search in Google Scholar
[140. Krause I, Monselise Y, Milo G, Weinberger A. Anti- Saccharomyces cerevisiae antibodies - A novel serologic marker for Behcet’s disease. Clin Exp Rheumatol. 2002; 20:S21-4.]Search in Google Scholar
[141. Fresko I, Ugurlu S, Ozbakir F, Celik A, Yurdakul S, Hamuryudan V, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet’s syndrome. Clin Exp Rheumatol. 2005; 23:S67-70.]Search in Google Scholar
[142. Choi CH, Kim TI, Kim BC, Shin SJ, Lee SK, Kim WH, et al. Anti-Saccharomyces cerevisiae antibody in intestinal Behcet’s disease patients: relation to clinical course. Dis Colon Rectum. 2006; 49:1849-59.10.1007/s10350-006-0706-z17080284]Open DOISearch in Google Scholar
[143. Kim BG, Kim YS, Kim JS, Jung HC, Song IS. Diagnostic role of Anti-Saccharomyces cerevisiae Mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Dis Colon Rectum. 2002; 45:1062-9.10.1007/s10350-004-6361-312195191]Open DOISearch in Google Scholar
[144. Krvavac S. Genitorectal trichomonas invasion as (co)-factor in pathogenesis of Behcet’s syndrome. Ann Rheum Dis. 1990; 49:423.10.1136/ard.49.6.423-a10041212383074]Open DOISearch in Google Scholar
[145. Behcet H. Uber rezidivierende, aphthose durch ein virus verursachte Geschwure am Mund, am Auge und am den Genitalen. Dermatol Wochenschr. 1937; 105:1152-7.]Search in Google Scholar
[146. Young C, Lehner T, Barnes CG. CD4 and CD8 cell responses to herpes simplex virus in Behcet’s disease. Clin Exp Immunol. 1988; 73:6-10.]Search in Google Scholar
[147. Hamzaoui K, Kahan A, Ayed K, Hamza M. Cytotoxic T cells against herpes simplex virus in Behcet’s disease. Clin Exp Immunol. 1990; 81:390-5.10.1111/j.1365-2249.1990.tb05344.x15349922168823]Search in Google Scholar
[148. Kotter I, Vonthein R, Gunaydin I, Muller CA, Zierhut M, Stubiger N. Behcet’s disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol. 2004; 31:133-9.]Search in Google Scholar
[149. Okada AA. Behcet’s disease: general concepts and recent advances. Curr Opin Ophthalmol. 2006; 17: 551-6.10.1097/01.icu.0000247411.59213.bb17065924]Open DOISearch in Google Scholar
[150. Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Epidemiological features of Adamantiades-Behcet’s disease in Germany and in Europe. Yonsei Med J. 1997; 38:411-22.10.3349/ymj.1997.38.6.4119509911]Open DOISearch in Google Scholar
[151. Tazi Mezalek Z, Harmouche H, El Attar N, Serraj K, Aouni M, Adnaoui M, et al. Kaposi’s sarcoma in association with Behcet’s disease: case report and literature review. Semin Arthritis Rheum. 2007; 36: 328-31.10.1016/j.semarthrit.2006.11.00117240427]Open DOISearch in Google Scholar
[152. Auzary C, Du Boutin LTH, Wechsler B, Chollet P, Piette JC. Disseminated nocardiosis presenting as a flare of Behcet’s disease. Rheumatology. 2001; 40: 949-52.10.1093/rheumatology/40.8.94911511773]Open DOISearch in Google Scholar
[153. Pamuk GE, Pamuk ON, Tabak F, Mert A, Ozturk R, Aktuglu Y. Systemic Nocardia infection in a patient with Behcet’s disease. Rheumatology. 2001; 40:597-9.10.1093/rheumatology/40.5.59711371678]Open DOISearch in Google Scholar
[154. Korkmaz C, Aydinli A, Erol N, Yildirim N, Akgun Y, Inci R, et al. Widespread nocardiosis in two patients with Behcet’s disease. Clin Exp Rheumatol. 2001; 19: 459-62.]Search in Google Scholar
[155. Arslan U, Tuncer I, Uysal EB, Inci R. Pleuropulmonary and soft tissue Nocardia cyriacigeorgici infection in a patient with Behcet’s disease. Saudi Med J. 2007; 28:1435-7.]Search in Google Scholar
[156. Ueda M, Kobayashi Y, Yoshimori K, Takahashi Y, Chikayama S, Ikeda M, et al. [Epstein-Barr virusinfected T-cell malignancy in an adult patient with Behcet’s disease-like symptoms.] Jpn J Clin Hematol. 1997; 38:657-62. (in Japanese)]Search in Google Scholar
[157. Finsterer J, Schmidbauer M. Lethal fulminate S. aureus sepsis in M. Behcet overnight cold exposure. Acta Medica Austriaca. 2002; 29:143-5.10.1046/j.1563-2571.2002.02023.x12424941]Open DOISearch in Google Scholar
[158. Skvara H, Duschek N, Karlhofer F. De novo tuberculosis during infliximab therapy in a patient with Behcet disease. J German Soc Dermatol. 2009; 7:616-8.]Search in Google Scholar
[159. Raychaudhuri SP, Siu S. Pneumocystis carinii pneumonia in patients receiving immunosuppressive drugs for dermatological diseases. Brit J Dermatol. 1999; 141:528-30.10.1046/j.1365-2133.1999.03052.x10583061]Open DOISearch in Google Scholar
[160. Kotter I, Aepinus C, Graepler F, Gartner V, Eckstein AK, Stubiger N, et al. HHV8 associated Kaposi’s sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behcet’s disease and complete remission of both disorders with interferon á. Ann Rheum Dis. 2001; 60:83-6.10.1136/ard.60.1.83175336511114291]Search in Google Scholar
[161. Malkin J, Shrimpton A, Wiselka M, Barer MR, Duddridge M, Perera N. Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet’s disease. J Med Microbiol. 2009; 58:371-3.10.1099/jmm.0.006809-019208889]Open DOISearch in Google Scholar
[162. Sari I, Birlik M, Gonen C, Akar S, Gurel D, Onen F, et al. Cytomegalovirus colitis in a patient with Behcet’s disease receiving tumor necrosis factor alpha inhibitory treatment. World J Gastroenterol. 2008; 14:2912-4.10.3748/wjg.14.2912271073718473420]Open DOISearch in Google Scholar
[163. Seddon ME, Thomas MG. Invasive disease due to Epidermophyton floccosum in an immunocompromised patient with Behcet’s syndrome. Clin Infect Dis. 1997; 25:153-4.10.1086/5168879243051]Open DOISearch in Google Scholar
[164. Cooper C, Pippard EC, Sharp H, Wickham C, Chamberlain MA, Barker DJP. Is Behcet’s disease triggered by childhood infection? Ann Rheum Dis. 1989; 48:421-3. 10.1136/ard.48.5.42110037732730167]Open DOISearch in Google Scholar